| [1] |
JIN Hong-jian.
The construction of tuberculosis prevention and control service system at county level in China needs to be strengthened urgently —— Comments and suggestions of an old tuberculosis control and prevention worker
[J]. Chinese Journal of Antituberculosis, 2020, 42(9): 896-902.
|
| [2] |
ZHANG Can-you, XIA Hui, CHENG Jun.
Testing and reporting requirements for Class Ⅱ biosafety cabinet in tuberculosis laboratory
[J]. Chinese Journal of Antituberculosis, 2020, 42(9): 903-909.
|
| [3] |
CHEN Yu-mei, LUO Xing-xiong, CHEN Cheng-jiang, SU Ping, WANG Chun-lei..
Analysis of the service capability in city/county tuberculosis designated hospital in Hainan
[J]. Chinese Journal of Antituberculosis, 2020, 42(9): 992-993.
|
| [4] |
LI Tao, DU Xin, CHEN Wei, HUANG Fei, ZHAO Yan-lin, ZHANG Hui.
Review and prospect of tuberculosis management information surveillance and monitoring in China
[J]. Chinese Journal of Antituberculosis, 2020, 42(7): 657-661.
|
| [5] |
SHEN Xin, SHA Wei, LIU Jian-jun.
Impact of coronavirus disease 2019 (COVID-19) on tuberculosis control and countermeasures in China
[J]. Chinese Journal of Antituberculosis, 2020, 42(6): 544-548.
|
| [6] |
SONG Qi-sheng, LU Xi-wei.
Progress and prospect of positron emission computed tomography applied in clinical research of pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2020, 42(6): 621-625.
|
| [7] |
CHENG Jun, LIU Jian-jun.
Current status and progress of surveillance and automated-alert for tuberculosis in school
[J]. Chinese Journal of Antituberculosis, 2020, 42(5): 436-441.
|
| [8] |
LI Zi-hui, ZHANG Zong-de.
Current situation and prospect of laboratory diagnosis of tuberculous meningitis
[J]. Chinese Journal of Antituberculosis, 2020, 42(5): 442-448.
|
| [9] |
LU Peng,CHENG Jun,LU Xi-wei,LIU Er-yong,ZHOU Lin,LU Wei.
Scientific preventive treatment to accelerate the process of tuberculosis control
[J]. Chinese Journal of Antituberculosis, 2020, 42(4): 316-321.
|
| [10] |
LIU Xi-fang,MA Gai-xia,GAN Jie,LU Zhen-hui,ZHANG Hui-yong,GUO Xiao-yan.
Application status and suggestion of quality of life scale for pulmonary tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2020, 42(3): 200-203.
|
| [11] |
FAN Lin,LIU Yi-dian,XIAO He-ping.
Characteristics and points analysis of national Guidelines on chemotherapy of drug-resistant tuberculosis (2019) and associated consensus
[J]. Chinese Journal of Antituberculosis, 2020, 42(2): 91-94.
|
| [12] |
LIANG Jian-qin, WU Xue-qiong.
Interpretation of Expert consensus on detection and clinical application of peripheral blood lymphocyte subsets in patients with tuberculosis
[J]. Chinese Journal of Antituberculosis, 2020, 42(12): 1276-1279.
|
| [13] |
LIU Yi-dian,GUI Xu-wei,SHEN Xiao-na,YU Yuan-yuan,YAO Lan,LOU Hai,SHA Wei,XIAO He-ping.
Interpretation of “An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline:Treatment of Drug-Resistant Tuberculosis” and comparison with “Guideline for Chemotherapy of Drug Resistant Tuberculosis(2019)” in China
[J]. Chinese Journal of Antituberculosis, 2020, 42(1): 12-16.
|
| [14] |
Hui ZHANG,Jian-jun LIU.
The overview and prospect of tuberculosis control in China since the founding of the People’s Republic of China
[J]. Chinese Journal of Antituberculosis, 2019, 41(9): 913-916.
|
| [15] |
Shi-wen JIANG,Xiao-qiu LIU.
Interpretation of key points and suggestion for the Health Management Service Specification for Tuberculosis Patients
[J]. Chinese Journal of Antituberculosis, 2019, 41(9): 926-929.
|
京公网安备11010202007215号
Total visitors: Visitors of today: Now online:
This work is licensed under Creative Commons Attribution 3.0 License.
